Accordingly, high expression of four major ABC transporters (ABCA2, MDR1, MRP1, and ABCG2) was detected in the SP fraction of six human lung cancer lines, which exhibited high drug resistance to multiple chemotherapeutics, several of which are conventionally used as first-line therapy for lung cancer [57]. This evidence concerns the gene ABCA2 and lung cancer.